SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
CVTX - CV Therapeutics, Inc.
An SI Board Since January 1999
Posts SubjectMarks Bans
411 31 0
Emcee:  Todd N. Weisrock Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
286CVTX is running up on no news. Q3 CC will take place on Oct 31 makes me wonder iidos-10/18/2006
285CV Therapeutics Ending Co-Promotion of ACEON(R) (perindopril erbumine) Tablets Wmopgcw-10/11/2006
284CV Therapeutics CEO to Sell Shares Monday September 25, 3:35 pm ET CV Therapeumopgcw-9/26/2006
283CVT's Looming Date With Destiny Tuesday September 26, 1:25 pm ET By Brian Lmopgcw-9/26/2006
282CV Therapeutics Completes MERLIN TIMI-36 Study Tuesday September 26, 7:00 am ET mopgcw-9/26/2006
281citi: CVTX: More Shares, More Shareholder Dilution - Reducing Target Price HOLmopgcw-9/4/2006
280CV Therapeutics Announces Seven Abstracts Accepted for Presentation at the Europmopgcw-8/26/2006
279CV Therapeutics Announces Pricing of Public Offering of 9,000,000 Shares of Commmopgcw-8/16/2006
278Lange has been a really arrogant ceo and arrogance doesn't often pay. $400M rkrw-8/14/2006
277unbelievable. the decision at this point is bizarre, is this management's emopgcw-8/14/2006
276CV Therapeutics Offers 7.5M Shares Monday August 14, 8:01 am ET CV Therapeutics dr.praveen-8/14/2006
275Citi: CVTX: Poor Ranexa Sales Continue - All Attention Turned To MERLIN HOLmopgcw-8/11/2006
274CIBC on CVTX: On 8/03, CVTX reported a 2Q06 loss per share of $1.59, above our idos-8/5/2006
273Don't think a lot of people on the street aren't enjoying watching Langerkrw-8/4/2006
272Thanks Praveen, better late than never... I had a bad feeling so did not wait anidos-8/4/2006
271yahoo summary of cc: 1. Managed Care: Medicate and Medicare understand the valumopgcw-8/4/2006
270CV Therapeutics Reports 2006 Second Quarter Financial Results Thursday August 3,mopgcw-8/4/2006
269Hi idos, Sorry I missed your post somehow. Cardiologists are a bunch of people dr.praveen-8/1/2006
268CVT-6883 asthma/inflammation: Here's the full text freebie jci.org Cheers,tuck-8/1/2006
267JCI Publishes Preclinical Study Evaluating Potential Ability of CVT-6883 for themopgcw-8/1/2006
266Doc why do you think Ranexa is not selling so well? I had the impression that itidos-7/27/2006
265CVTX :Downgrading To MP—Month Two Growth Falls Short 2006-06-15 02:21 (mopgcw-7/12/2006
264CV Therapeutics Acquires Rights to Ranolazine in Asia Thursday June 22, 7:00 am dr.praveen-6/25/2006
263CV, PTC Sign Development Agreement Monday June 12, 3:18 pm ET CV Therapeutics, Pdr.praveen-6/25/2006
262JACC Publishes ERICA Trial Results Showing Ranexa(R) Reduces Angina Frequency anmopgcw-6/21/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News